Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

[1]  S. Vicent,et al.  The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma. , 2022, The Journal of investigative dermatology.

[2]  Weinan Guo,et al.  Metabolic rewiring directs melanoma immunology , 2022, Frontiers in Immunology.

[3]  F. Zouein,et al.  Role of ranolazine in heart failure: From cellular to clinic perspective. , 2022, European journal of pharmacology.

[4]  Rui Hu,et al.  PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer , 2022, Frontiers in Immunology.

[5]  G. McArthur,et al.  Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies , 2021, Cancers.

[6]  P. Ascierto,et al.  Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy , 2021, Frontiers in Oncology.

[7]  S. Spencer,et al.  Melanoma subpopulations that rapidly escape MAPK pathway inhibition incur DNA damage and rely on stress signalling , 2021, Nature Communications.

[8]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[9]  C. Wellbrock,et al.  Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in Glioblastoma , 2021, Cancers.

[10]  M. Caraglia,et al.  S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a , 2020, International journal of molecular sciences.

[11]  F. André,et al.  Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation. , 2020, Cell reports.

[12]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[13]  K. Flaherty,et al.  Reversal of pre-existing NGFR-driven tumor and immune therapy resistance , 2020, Nature Communications.

[14]  I. Csabai,et al.  S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression , 2020, Cells.

[15]  Z. Ronai,et al.  PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity , 2020, Science Translational Medicine.

[16]  Koichi S. Kobayashi,et al.  MHC class I transactivator NLRC5 in host immunity, cancer and beyond , 2020, Immunology.

[17]  M. Simoes-Costa,et al.  Metabolic Reprogramming Promotes Neural Crest Migration via Yap/Tead Signaling. , 2020, Developmental cell.

[18]  R. Garzon,et al.  PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease. , 2020, JCI insight.

[19]  J. Locasale,et al.  Methionine metabolism in health and cancer: a nexus of diet and precision medicine , 2019, Nature Reviews Cancer.

[20]  I. Barshack,et al.  Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence , 2019, Cell.

[21]  C. Wellbrock,et al.  Phenotype plasticity as enabler of melanoma progression and therapy resistance , 2019, Nature Reviews Cancer.

[22]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[23]  Oscar Franzén,et al.  PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data , 2019, Database J. Biol. Databases Curation.

[24]  R. Satija,et al.  Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression , 2019, Genome Biology.

[25]  Camille Stephan-Otto Attolini,et al.  Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging , 2018, Cell.

[26]  H. Takayanagi,et al.  Arginine methylation controls the strength of γc-family cytokine signaling in T cell maintenance , 2018, Nature Immunology.

[27]  K. Flaherty,et al.  Toward Minimal Residual Disease-Directed Therapy in Melanoma , 2018, Cell.

[28]  Kevin R. Moon,et al.  Recovering Gene Interactions from Single-Cell Data Using Data Diffusion , 2018, Cell.

[29]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[30]  P. Parren,et al.  Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors , 2018, Nature Medicine.

[31]  Yiling Lu,et al.  A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. , 2017, Cell reports.

[32]  G. Freeman,et al.  Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. , 2017, Cancer cell.

[33]  P. Carmeliet,et al.  A Fatty Acid Oxidation-Dependent Metabolic Shift Regulates Adult Neural Stem Cell Activity , 2017, Cell reports.

[34]  C. Wellbrock,et al.  PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. , 2017, Cell reports.

[35]  Robert Damoiseaux,et al.  Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression , 2017, Cell reports.

[36]  A. D’Alessandro,et al.  A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. , 2017, Rapid communications in mass spectrometry : RCM.

[37]  K. Flaherty,et al.  Targeted agents and immunotherapies: optimizing outcomes in melanoma , 2017, Nature Reviews Clinical Oncology.

[38]  T. Honjo,et al.  Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity , 2017, Proceedings of the National Academy of Sciences.

[39]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[40]  A. Kernytsky,et al.  MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis. , 2016, Cell reports.

[41]  T. Golub,et al.  MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells , 2016, Science.

[42]  Konstantinos J. Mavrakis,et al.  Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5 , 2016, Science.

[43]  K. Flaherty,et al.  Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy , 2016, Cancer cell.

[44]  N. Dhomen,et al.  Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells , 2015, Molecular oncology.

[45]  R. Lo,et al.  Vemurafenib resistance reprograms melanoma cells towards glutamine dependence , 2015, Journal of Translational Medicine.

[46]  S. Shen-Orr,et al.  Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. , 2015, Cell metabolism.

[47]  A. Regev,et al.  Spatial reconstruction of single-cell gene expression , 2015, Nature Biotechnology.

[48]  Jun S. Song,et al.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.

[49]  R. Marais,et al.  Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma , 2012, Journal of the National Cancer Institute.

[50]  D. Iliopoulos,et al.  NLR family member NLRC5 is a transcriptional regulator of MHC class I genes , 2010, Proceedings of the National Academy of Sciences.

[51]  J. Reis-Filho,et al.  Oncogenic Braf induces melanocyte senescence and melanoma in mice. , 2009, Cancer cell.

[52]  P. Oefner,et al.  Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[53]  M. Schartl,et al.  Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc. , 1999, European journal of biochemistry.

[54]  K. M. Wyatt,et al.  Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism. , 1996, Journal of molecular and cellular cardiology.

[55]  K. Sakaguchi,et al.  Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. , 1995, Journal of immunology.

[56]  F. Roels,et al.  Thioridazine: a selective inhibitor of peroxisomal β‐oxidation in vivo , 1985 .